Sandra Lueken joined StrideBio as Vice President of Quality Operations in March 2021. Ms. Lueken has over 25 years of industry experience driving quality innovation while assuring product quality at prior companies including KBI Biopharma, AstraZeneca, MedImmune and Baxter Healthcare. Ms. Lueken has participated in multiple drug approvals and believes in a risk-based, phase appropriate, lean approach to quality and setting up systems and processes for success.
Ms. Lueken holds an M.B.A. from University of Arizona’s Eller Graduate School of Management and a B.A. degree in Biochemistry from the University of Arizona.